Commodore Capital’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$29.8M Hold
2025
Q1
$32.1M Hold
2024
Q4
$46.3M Hold
2024
Q3
$58.5M Hold
2024
Q2
$46.7M Buy
2024
Q1
$71.5M Hold
2023
Q4
$40.5M Buy
2023
Q3
$1.42M Hold
2023
Q2
$1.31M Buy